Trimethoprim-sulfamethoxazole in the treatment of bacteriuria in women.
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000553:Ambulatory Care; D000667:Ampicillin / Q000627:therapeutic use; D001437:Bacteriuria / Q000188:drug therapy*; D002506:Cephalexin; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004739:England; D005194:Family Practice; D005260:Female; D005500:Follow-Up Studies; D006402:Hematologic Diseases / Q000139:chemically induced; D006760:Hospitalization; D006801:Humans; D007231:Infant, Newborn; D008826:Microbial Sensitivity Tests; D010919:Placebos; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D013420:Sulfamethoxazole / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D014295:Trimethoprim / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use
D004338:Drug Combinations; D010919:Placebos; D000667:Ampicillin; D014295:Trimethoprim; D013420:Sulfamethoxazole; D002506:Cephalexin